🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/05/2019 | 78,67 | 80,52 | 77,54 | 78,43 | -0,10% | 3,79% | 440.344 |
| 30/04/2019 | 78,50 | 79,58 | 76,82 | 78,51 | -0,22% | 3,52% | 482.984 |
| 29/04/2019 | 79,71 | 80,17 | 78,14 | 78,68 | -0,76% | 2,55% | 375.423 |
| 26/04/2019 | 77,64 | 79,64 | 76,89 | 79,28 | +2,27% | 3,54% | 369.652 |
| 25/04/2019 | 77,59 | 78,38 | 76,18 | 77,52 | +0,34% | 2,84% | 352.500 |
| 24/04/2019 | 79,73 | 80,03 | 76,69 | 77,26 | -3,53% | 4,19% | 671.336 |
| 23/04/2019 | 78,60 | 81,19 | 77,19 | 80,09 | +2,01% | 5,08% | 734.014 |
| 22/04/2019 | 76,08 | 79,36 | 76,08 | 78,51 | +3,06% | 4,32% | 623.727 |
| 18/04/2019 | 74,70 | 76,41 | 74,01 | 76,18 | +1,85% | 3,21% | 418.383 |
| 17/04/2019 | 78,24 | 78,24 | 73,46 | 74,79 | -3,87% | 6,11% | 809.675 |
| 16/04/2019 | 79,00 | 79,79 | 77,28 | 77,80 | -0,86% | 3,17% | 434.092 |
| 15/04/2019 | 79,83 | 81,10 | 78,04 | 78,47 | -1,60% | 3,83% | 468.076 |
| 12/04/2019 | 80,05 | 81,41 | 79,18 | 79,75 | +0,00% | 2,79% | 570.668 |
| 11/04/2019 | 78,46 | 80,45 | 78,46 | 79,75 | -0,23% | 2,54% | 427.360 |
| 10/04/2019 | 78,33 | 80,41 | 77,54 | 79,94 | +2,36% | 3,66% | 364.843 |
| 09/04/2019 | 79,94 | 80,36 | 77,94 | 78,10 | -2,77% | 3,03% | 407.964 |
| 08/04/2019 | 80,42 | 80,69 | 79,29 | 80,32 | -0,45% | 1,74% | 430.085 |
| 05/04/2019 | 80,04 | 81,40 | 79,33 | 80,69 | +1,22% | 2,60% | 448.840 |
| 04/04/2019 | 79,18 | 80,17 | 78,74 | 79,71 | +0,52% | 1,81% | 608.659 |
| 03/04/2019 | 77,57 | 79,53 | 76,84 | 79,30 | +2,96% | 3,47% | 538.448 |
| 02/04/2019 | 77,70 | 77,98 | 76,61 | 77,02 | -0,44% | 1,77% | 493.564 |
| 01/04/2019 | 79,23 | 79,73 | 77,19 | 77,36 | -1,35% | 3,21% | 491.640 |
| 29/03/2019 | 77,76 | 78,98 | 77,18 | 78,42 | +1,76% | 2,31% | 541.333 |
| 28/03/2019 | 75,37 | 77,16 | 75,32 | 77,06 | +2,25% | 2,45% | 332.302 |
| 27/03/2019 | 76,80 | 76,86 | 75,09 | 75,36 | -1,89% | 2,31% | 483.785 |
| 26/03/2019 | 77,57 | 77,64 | 75,64 | 76,82 | +0,01% | 2,58% | 591.988 |
| 25/03/2019 | 77,64 | 78,50 | 76,02 | 76,81 | -1,39% | 3,19% | 635.429 |
| 22/03/2019 | 79,89 | 80,83 | 77,89 | 77,89 | -3,34% | 3,69% | 933.427 |
| 21/03/2019 | 76,36 | 80,79 | 75,89 | 80,58 | +4,42% | 6,41% | 1.013.577 |
| 20/03/2019 | 77,37 | 78,53 | 76,09 | 77,17 | -0,26% | 3,14% | 787.394 |